Journal
ACTA NEUROPATHOLOGICA COMMUNICATIONS
Volume 7, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s40478-019-0800-9
Keywords
Sterile alpha and TIR motif-containing protein 1; Amyotrophic lateral sclerosis; TAR DNA-binding protein 43; Wallerian degeneration; Axonal protection; Dendritic spines
Categories
Funding
- Motor Neuron Disease Association
- Medical Research Council UK
- Lady Edith Wolfson Fellowship Fund
- van Geest Foundation
- Rosetrees Trust
- Alzheimer's Research UK
- Psychiatry Research Trust
- Chinese Scholarship Council
- MRC [MR/K010611/1] Funding Source: UKRI
Ask authors/readers for more resources
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative condition that primarily affects the motor system and shares many features with frontotemporal dementia (FTD). Evidence suggests that ALS is a 'dying-back' disease, with peripheral denervation and axonal degeneration occurring before loss of motor neuron cell bodies. Distal to a nerve injury, a similar pattern of axonal degeneration can be seen, which is mediated by an active axon destruction mechanism called Wallerian degeneration. Sterile alpha and TIR motif-containing 1 (Sarm1) is a key gene in the Wallerian pathway and its deletion provides long-term protection against both Wallerian degeneration and Wallerian-like, non-injury induced axonopathy, a retrograde degenerative process that occurs in many neurodegenerative diseases where axonal transport is impaired. Here, we explored whether Sarm1 signalling could be a therapeutic target for ALS by deleting Sarm1 from a mouse model of ALS-FTD, a TDP-43(Q331K), YFP-H double transgenic mouse. Sarm1 deletion attenuated motor axon degeneration and neuromuscular junction denervation. Motor neuron cell bodies were also significantly protected. Deletion of Sarm1 also attenuated loss of layer V pyramidal neuronal dendritic spines in the primary motor cortex. Structural MRI identified the entorhinal cortex as the most significantly atrophic region, and histological studies confirmed a greater loss of neurons in the entorhinal cortex than in the motor cortex, suggesting a prominent FTD-like pattern of neurodegeneration in this transgenic mouse model. Despite the reduction in neuronal degeneration, Sarm1 deletion did not attenuate age-related behavioural deficits caused by TDP-43(Q331K). However, Sarm1 deletion was associated with a significant increase in the viability of male TDP-43(Q331K) mice, suggesting a detrimental role of Wallerian-like pathways in the earliest stages of TDP-43(Q331K)-mediated neurodegeneration. Collectively, these results indicate that anti-SARM1 strategies have therapeutic potential in ALS-FTD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available